Loading

Despite its promise, however, the digital health landscape today is highly fragmented. The result is a myriad of digital health projects and applications that rarely reach scale and if they were to expand could even strain the health system. An...

The burden of invasive pneumococcal disease in young children decreased dramatically following introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). The epidemiology of S. pneumoniae now reflects infections caused by serotypes not...

Pertussis incidence has been increasing for the past two decades in Norway, as in much of the highly vaccinated world. The greatest increase is in teenagers, although the most severe cases occur in infants. A teenage booster is recommended globally,...

Little is known about how long the BCG vaccine protects against tuberculosis. This study assessed the long-term vaccine effectiveness (VE) in Norwegian-born individuals.

Rotavirus gastroenteritis is a vaccine-preventable disease that confers a high medical and economic burden in more developed countries and can be fatal in less developed countries. Two vaccines with high efficacy and good safety profiles were...

Recently an investigational meningococcal B vaccine has been used in two college outbreaks in the US. This is the first time that a meningococcal B vaccine has been used for outbreak control in the US. However, strain specific vaccines for...

This presentation describes Norway\'s electronic immunisation registry system- including data reporting- data security- calculating vaccination coverage based on the registry system- data validation- and some of the challenges of the registry...

The Norwegian immunisation register- SYSVAK- is a national electronic immunisation register. It became nationwide in 1995. The major aim was to register all vaccinations in the Childhood Immunisation Programme to ensure that all children are offered...

Forum Post

Progress in NITAGs in WHO EURO region

June 24th 2016

As WHO and UNICEF are collecting the JRF for the year 2015, results are showing that there were still 11 countries (out of 53) in the WHO EURO Region declaring not to have a National Immunization T

  • Organisation: UNICEF WHO
  • Country: Sweden Norway Italy
  • Forum Post

    e-learning course in immunization for programme managers in India

    December 18th 2013

    [i]Narottam Pradhan shares this announcement with forum readers. Thank you![/i] An online e learning course has been developed by the National Institute of Health and Family Welfare, India with sup

  • Country: Norway India
  • Forum Post

    POST 01401E: RESURGENCE OF MEASLES

    March 11th 2009

    POST 01401E: RESURGENCE OF MEASLES 11 MARCH 2009 ****************************************** In some countries where measles was near elimination there has been a sudden resurgence of the dis

  • Country: Switzerland Norway Germany France Austria
  • Disease: Measles
  • Forum Post

    POST 00993E : REFRIGERANT GASES

    October 17th 2006

    POST 00993E : REFRIGERANT GASES 17 October 2006 ___________________________________________ The message below comes from Anthony Battersby (mailto:[email protected]) from the United Kingdom.

  • Country: Norway Canada
  • Forum Post

    Forum Post

    POST 00457E : GAVI UPDATE

    May 29th 2002

    POST 00457E : GAVI UPDATE 29 May 2002 __________________________________________ Hemanthi Dassanayake is sharing with us GAVI Update of 23 May 2002. If you have any information or modifications

  • Country: Sweden South Africa Senegal Norway Nepal Indonesia Ghana Bhutan Bangladesh Azerbaijan Armenia Albania
  • Disease: Rotavirus Hepatitis B HIB
  • Forum Post

    POST00391E - PROTECTION OF MORE COLD SENSITIVE VACCINES

    November 27th 2001

    Post00391E PROTECTION OF MORE COLD SENSITIVE VACCINES 26 November 2001 ************************* 1. Background 2. Can we return back to the 4-8°C recommended refrigeration range of the 1

  • Country: South Africa Norway Indonesia India
  • Disease: Tetanus Hepatitis B HIB
  • Vaccine management
  • Forum Post

    POST00391E - PROTECTION OF MORE COLD SENSITIVE VACCINES

    November 27th 2001

    Post00391E PROTECTION OF MORE COLD SENSITIVE VACCINES 26 November 2001 ************************* 1. Background 2. Can we return back to the 4-8°C recommended refrigeration range of the 1

  • Country: South Africa Norway Indonesia India
  • Disease: Tetanus Hepatitis B HIB
  • Vaccine management
  • Forum Post

    POST00391E - PROTECTION OF MORE COLD SENSITIVE VACCINES

    November 27th 2001

    Post00391E PROTECTION OF MORE COLD SENSITIVE VACCINES 26 November 2001 ************************* 1. Background 2. Can we return back to the 4-8°C recommended refrigeration range of the 1

  • Country: South Africa Norway Indonesia India
  • Disease: Tetanus Hepatitis B HIB
  • Vaccine management
  • Forum Post

    POST00391E - PROTECTION OF MORE COLD SENSITIVE VACCINES

    November 27th 2001

    Post00391E PROTECTION OF MORE COLD SENSITIVE VACCINES 26 November 2001 ************************* 1. Background 2. Can we return back to the 4-8°C recommended refrigeration range of the 1

  • Country: South Africa Norway Indonesia India
  • Disease: Tetanus Hepatitis B HIB
  • Vaccine management
  • We don't have any Hbr resources
    We don't have any events
    We don't have any jobs
    No hot topics found!